Codification of Medicare Drug Price Negotiation: What the Final Rule Means for Manufacturers November 12, 2026
Artificial Intelligence in HEOR: From Potential to Practice in Standards, Oversight, and Real-World Implications October 28, 2026
Oncology’s 2027 Access Challenge: Why Provider Economics May Matter as Much as Payer Coverage October 12, 2026
Prelaunch Product Evaluations: When Label-Based Assumptions Don't Tell the Whole Story September 25, 2026